News
Media
Between the LinesExpert InterviewsK-CastMedical World NewsPodcastsPopulation Health Perspectives
Conferences
Partners
More
Publications
All PublicationsMHE PublicationFormulary Watch SupplementsFormulary Watch SpotlightsSupplements And Featured Publications
Events
Webinars
CME/CE
Resources
PBMI InnovatorsEmerging LeadersInteractive ToolsSponsored Content
PBM Directory

Subscribe

  • News
  • Media
  • Conferences
  • Partners
  • Publications
  • Events
  • CME/CE
  • Resources
  • PBM Directory
  • Subscribe
  • Asthma
  • Atrial Fibrillation
  • Autoimmune Diseases
  • Biologics
  • Biosimilars
  • Blood Cancer
  • Breast Cancer
  • COVID-19
  • Cardiovascular Diseases
  • Depression
  • Dermatology
  • Diabetes
  • Digital Health
  • Drug Coverage
  • Duchenne Muscular Dystrophy
  • Eyecare
  • FDA
  • Friedreich Ataxia
  • Gene Therapy
  • Graft Versus Host Disease
  • HIV
  • Health Systems
  • Heart Failure
  • Hemophilia
  • Hypertrophic Cardiomyopathy (HCM)
  • Infectious Disease
  • Leukemia and Lymphoma
  • Liver Disease
  • Lung Cancer
  • Mental Health
  • Multiple Sclerosis
  • NSCLC
  • Neonatal Care
  • Nephrology
  • Obstetrics-Gynecology & Women's Health
  • Oncology
  • Oncology Biomarkers
  • Opioids
  • PTSD
  • Pain
  • Pediatrics
  • Plaque Psoriasis
  • Population Health
  • Post-Acute Care
  • Prescription Digital Therapeutics
  • Pulmonary Arterial Hypertension
  • RSV
  • Reproductive Health
  • Respiratory Conditions
  • Safety & Recalls
  • Schizophrenia
  • Shingles
  • Skin Cancer
  • Sleep Disorders
  • Solid Tumors
  • Spinal Muscular Atrophy
  • Substance Use Disorder
  • The Improving Patient Access Podcast
  • Type I Diabetes
  • Type II Inflammation
  • Ulcerative Colitis
  • Uro-Oncology
  • Urothelial Carcinoma
  • Vaccines
  • Women's Health
  • Year in Review- Dermatology
Spotlight -
MHE State of the Industry survey|
ASH 2025|
AMCP Nexus 2025|
2025 Fall Clinical Dermatology|
ASRS 2025
Advertisement
News|Articles|March 1, 2003

Amevive (Alefacept)

NME: First biologic treatment approved for psoriasis

Advertisement

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Advertisement

Related Content

Advertisement

Winter exposes how closely eczema, asthma and allergies are linked

ByBriana Contreras
December 22nd 2025
 IMG visuals icons-stock@adobe.com

Health system pharmacy leaders are worried about 340B, ACA changes, survey finds

ByDenise Myshko
December 16th 2025

Japanese study finds vitiligo has a strong impact on daily life and mental health

ByBriana Contreras
December 12th 2025
FDA approved | Image credit: wladimir1804 - stock.adobe.com

2025 FDA dermatology approvals: A new gene therapy and two targeted therapies

ByLaura Joszt, MA
December 9th 2025

Adults with atopic dermatitis may sleep less because of the stress the condition causes

ByBriana Contreras
December 3rd 2025
Advertisement
Advertisement

Trending on Managed Healthcare Executive

1

Top 5 news articles of 2025

2

Top 5 women’s health news articles of 2025

3

Jascayd gets second FDA approval, this time for progressive pulmonary fibrosis

4

Top 5 stories from Formulary Watch in 2025

5

5 developments in the treatment of prurgio nodularis in 2025

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Formulary Watch
  • Pharmacy Benefit Management Institute
Managed Healthcare Executive
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us